Who Exports Arishta from India — 153 Suppliers Behind a $1.4M Market
India's arishta export market is supplied by 153 active exporters who collectively shipped $1.4M across 3,193 shipments. DABUR INDIA LIMITED leads with a 41.0% market share, followed by GREENSHIP EXPORTS and SREE EXPORTS. The top 5 suppliers together control 70.3% of total export value, reflecting a concentrated market structure.
Top Arishta Exporters from India — Ranked by Export Value
DABUR INDIA LIMITED is the leading arishta exporter from India, holding a 41.0% share of the $1.4M market across 3,193 shipments from 153 exporters. The top 5 suppliers — DABUR INDIA LIMITED, GREENSHIP EXPORTS, SREE EXPORTS, MULTANI PHARMACEUTICALS LIMITED, SANIYA EXPORTS & IMPORTS — collectively control 70.3% of total export value, indicating a highly concentrated market. Individual shares are: DABUR INDIA LIMITED (41.0%), GREENSHIP EXPORTS (20.6%), SREE EXPORTS (3.6%), MULTANI PHARMACEUTICALS LIMITED (2.6%), SANIYA EXPORTS & IMPORTS (2.6%).
Top Arishta Exporters from India
Ranked by export value · 153 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | DABUR INDIA LIMITED DASHMULARISHTA 450 ML NEPALDASHMULARISHTA 450 MLASHOKARISHTA 450 ML NEPAL | $590.0K | 2 | 41.0% |
| 2 | GREENSHIP EXPORTS SARASWATARISHTAMVASAKADYARISHTAMJIRAKADYARISHTAM | $297.0K | 4 | 20.6% |
| 3 | SREE EXPORTS DASAMULARISHTAM 450MLJIRAKADYARISHTAM 450MLASWAGANDHARISHTAM 450ML | $51.2K | 1 | 3.6% |
| 4 | MULTANI PHARMACEUTICALS LIMITED DASHMULARISHTA 450 ML NEPALDASHMULARISHTA 450 MLASHOKARISHTA 450 ML NEPAL | $37.9K | 1 | 2.6% |
| 5 | SANIYA EXPORTS & IMPORTS DASAMULARISHTAM 450MLJIRAKADYARISHTAM 450MLASWAGANDHARISHTAM 450ML | $36.7K | 1 | 2.6% |
| 6 | THE ARYA VAIDYA PHARMACY (COIMBATORE) LIMITED DASHMULARISHTA 450 ML NEPALDASHMULARISHTA 450 MLASHOKARISHTA 450 ML NEPAL | $36.5K | 5 | 2.5% |
| 7 | THE ARYA VAIDYA PHARMACY COIMBATORE LIMITED DASHMULARISHTA 450 ML NEPALDASHMULARISHTA 450 MLASHOKARISHTA 450 ML NEPAL | $35.6K | 3 | 2.5% |
| 8 | JANUZ UNIVERSAL AMLA JUICE, ONION OIL, ZANDU PANCHARISHTAASHOKARISTHA SYRUP, DASHMULARISHTASYRUP, SHANKHPUSHPI SYRUPASHOKARISTHA SYRUP, DASHMULARISHTASYRUP | $26.5K | 2 | 1.8% |
| 9 | SANIYA EXPORTS IMPORTS DASAMULARISHTAM 450MLJIRAKADYARISHTAM 450MLASWAGANDHARISHTAM 450ML | $21.1K | 1 | 1.5% |
| 10 | ASHTANGA VAIDYAM AYURVEDICS SARASWATARISHTAMVASAKADYARISHTAMJIRAKADYARISHTAM | $15.3K | 5 | 1.1% |
| 11 | KAIRALI EXPORTS DASAMULARISHTAM 450MLJIRAKADYARISHTAM 450MLASWAGANDHARISHTAM 450ML | $14.5K | 2 | 1.0% |
| 12 | 3PHALA AYURCENTRE PRIVATE LIMITED SARASWATARISHTAM -450MLARAGWADHARISHTAM -450MLDASAMULARISHTAM -450ML | $14.2K | 1 | 1.0% |
| 13 | VAIDYARATNAM OUSHADHASALA PRIVATE LIMITED DASAMULARISHTAM 450MLJIRAKADYARISHTAM 450MLASWAGANDHARISHTAM 450ML | $12.9K | 5 | 0.9% |
| 14 | KOOTHADEES TRADE PRIVATE LIMITED DASAMULARISHTAM 450MLJIRAKADYARISHTAM 450MLASWAGANDHARISHTAM 450ML | $12.6K | 1 | 0.9% |
| 15 | NAGARJUNA HERBAL CONCENTRATES LTD AMLA JUICE, ONION OIL, ZANDU PANCHARISHTAASHOKARISTHA SYRUP, DASHMULARISHTASYRUP, SHANKHPUSHPI SYRUPASHOKARISTHA SYRUP, DASHMULARISHTASYRUP | $11.8K | 4 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Arishta exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| DABUR INDIA LIMITED | Not Listed | Yes | No | Not verified | Dabur India Limited has achieved WHO-GMP compliance, enhancing its international |
| THE ARYA VAIDYA PHARMACY (COIMBATORE) LIMITED | Not Listed | Yes | No | Not verified | The Arya Vaidya Pharmacy (Coimbatore) Limited is recognized as a WHO-GMP certifi |
| VAIDYARATNAM OUSHADHASALA PRIVATE LIMITED | Not Listed | Yes | No | Not verified | Vaidyaratnam Oushadhasala Private Limited holds WHO-GMP certification, affirming |
TransData Nexus reviewed the regulatory standing of 3 leading Arishta exporters from India. 0 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Arishta sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city's pharmaceutical sector is bolstered by a robust infrastructure, including research institutions and manufacturing facilities, making it a pivotal hub for bulk drug manufacturing. While Hyderabad's primary focus is on APIs, its comprehensive pharmaceutical ecosystem may offer opportunities for sourcing raw materials essential for the production of Ayurvedic formulations like Arishta.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. This region hosts numerous companies specializing in the production of finished dosage forms, including tablets, capsules, and liquid formulations. The presence of advanced manufacturing facilities and a skilled workforce makes this cluster a strategic location for sourcing Arishta, ensuring adherence to quality standards and regulatory compliance.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Proximity to major ports like Jawaharlal Nehru Port Trust (JNPT) facilitates efficient international distribution. This region's well-established logistics and export infrastructure can streamline the export processes for Arishta, enhancing supply chain efficiency and reducing lead times.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical hub, partly due to favorable tax incentives offered by the state government. The region hosts a multitude of pharmaceutical manufacturing units, including those producing Ayurvedic products. The cost advantages and supportive regulatory environment make Baddi-Nalagarh an attractive option for sourcing Arishta.
5Sourcing Recommendations
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities of suppliers in the Ahmedabad-Vadodara region to ensure they can meet quality and volume requirements for Arishta.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad area to facilitate efficient international distribution of Arishta.
- Consider Cost Advantages: Explore sourcing opportunities in Baddi-Nalagarh to benefit from tax incentives and potentially lower production costs.
- Ensure Regulatory Compliance: Verify that suppliers across these clusters comply with relevant regulatory standards to maintain product quality and market acceptance.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can optimize the sourcing and distribution of Arishta, aligning with both quality standards and cost-effectiveness.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Arishta exporters from India
Dabur India Limited — Dabur India Limited acquires Sesa Care Pvt. Ltd.
Dabur India Limited announced the acquisition of Sesa Care Pvt. Ltd., a company specializing in Ayurvedic hair care products. This strategic move aims to strengthen Dabur's position in the Ayurvedic personal care market. - IMPACT: The acquisition is expected to enhance Dabur's product portfolio, potentially increasing its Arishta exports.
Impact: The acquisition is expected to enhance Dabur's product portfolio, potentially increasing its Arishta exports.
Dabur India Limited — Dabur India Limited launches Siens nutraceuticals brand
Dabur India Limited entered the nutraceuticals segment with the launch of its new wellness brand, Siens, offering products like marine collagen and multivitamins. This expansion aligns with Dabur's growth strategy targeting the health and wellness market. - IMPACT: While not directly related to Arishta, this diversification may influence Dabur's overall export strategy.
Impact: While not directly related to Arishta, this diversification may influence Dabur's overall export strategy.
Dabur India Limited — Dabur India Limited signs MoU for new manufacturing facility in Tamil Nadu
Dabur India Limited signed a Memorandum of Understanding with the Government of Tamil Nadu to establish a new manufacturing facility in SIPCOT Tindivanam. The facility will focus on producing products like Dabur Honey and Red Toothpaste, with an initial investment of ₹135 Crore. - IMPACT: The new facility may increase production capacity, potentially affecting Arishta export volumes.
Impact: The new facility may increase production capacity, potentially affecting Arishta export volumes.
Common Questions — Arishta Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which arishta supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, DABUR INDIA LIMITED leads with 272 recorded shipments worth $590.0K. GREENSHIP EXPORTS (524 shipments) and SREE EXPORTS (234 shipments) are also established high-volume exporters.
Q How many arishta manufacturers are there in India?
India has 153 active arishta exporters with a combined export market of $1.4M across 3,193 shipments to 47 countries. The top 5 suppliers hold 70.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for arishta from India?
Average FOB unit price: $6.89 per unit, ranging from $0.02 to $1969.30. Average shipment value: $451.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 153 verified Indian exporters of Arishta ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 3,193 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 47 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,193 Verified Shipments
153 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists